echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > All the medical people listed by the State Supervision Commission have paid attention to it

    All the medical people listed by the State Supervision Commission have paid attention to it

    • Last Update: 2018-03-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Cypress blue 2018-03-26 according to CCTV news, on March 23, the State Supervision Commission of the people's Republic of China opened its brand in Beijing, holding the constitutional oath ceremony for the new vice chairman and member of the State Supervision Commission ▍ the State Supervision Committee is here! On March 11, the first session of the 13th National People's Congress deliberated and passed the amendment to the constitution, and the supervisory committee was officially written into the constitution The Ministry of supervision shall be incorporated into the newly established state supervision commission, and the Ministry of supervision and the State Corruption Prevention Bureau shall no longer be retained As a national anti-corruption organization, the supervisory committee is parallel to the "one government, two courts" (the State Council, the Supreme People's court and the Supreme People's Procuratorate) On March 20, the first session of the 13th National People's Congress voted to adopt the supervision law of the people's Republic of China This institutional reform of the State Council is of great significance in giving the supervisory committee the constitutional status, and upgrading the reform practice results to the constitutional provisions, which provides the constitutional basis for the formulation of the supervisory law and the establishment of national and local supervisory committees at all levels In addition, when the premier of the State Council made the report on the work of the government in 2018, he repeatedly mentioned the word "anti-corruption", which shows that anti-corruption work is absolutely the top priority of the work in 2018 ▍ attention, the anti-corruption pressure continues! In fact, the battle against medical corruption, which has no smoke of gunpowder, can't stop from the moment the trumpet blows As early as October 28, 2009, the supervision department of the Central Commission for Discipline Inspection launched the national website for Discipline Inspection, supervision and reporting The report website accepts complaints from the masses about violations of Party discipline and administrative discipline by Party members, Party organizations and administrative supervision objects, as well as opinions and suggestions on the construction of a clean and Honest Party style and anti-corruption work In the five aspects of the party's encouragement of reporting, including the violation of the responsibility system of the construction of party conduct and clean government The details are as follows: Party committees at or above the county level fail to perform their main responsibilities and discipline inspection committees fail to perform their supervision responsibilities, resulting in corruption cases in their own departments and systems, or major corruption cases in a short period of time; local departments at or above the county level violate the spirit of the central government's eight regulations, and have serious "four winds" problems, which lead to ineffective accountability As we all know, in recent years, there have been many cases of corruption in the medical industry According to the information disclosure network of the most advanced inspection cases: in November 2017, Huang Mou, former Secretary of the Party committee of Gannan Medical College (at the level of the main hall), was suspected of bribery, which led to a nest case of medical corruption; in 2017, the nest case broke out in the health and medical system of Hefei, and 30 health system officials, hospital directors, doctors, etc were arrested and put on the file for investigation In April 2017, corruption cases broke out in Jiangsu liangkong hospital: four people in Changzhou De'an hospital were put on file for investigation due to bribery; five department heads of Wuxi Jiangyin people's Hospital and the laboratory of the hospital were all prosecuted for bribery In February 2015, after the national health and Family Planning Commission issued the inspection plan for large hospitals (2015-2017), the provincial health and family planning commissions successively launched the inspection plan for large hospitals, and the key point of inspection in hospitals is anti-corruption In July 2015, nine ministries and commissions, including the state health and Family Planning Commission, the national development and Reform Commission, the Ministry of industry and information technology, the Ministry of finance, the Ministry of human resources and social security, the Ministry of Commerce, the State Administration of Taxation, the State Administration for Industry and commerce, and the State Food and Drug Administration jointly issued the key points of 2015 rectification of improper special practices in pharmaceutical purchase and sale and medical services, and many ministries and commissions worked together to fight against medical corruption and further control commercial bribery in the field of pharmaceutical purchase and sale At the end of 2016, after CCTV exposed the "kickback door", a series of special medical anti-corruption actions were launched around the country At that time, a person familiar with the matter said that the nine ministries and commissions would work together to carry out a major campaign in the field of drug purchase and sale, in which the Ministry of public security would also participate The main objects of inspection were hospitals, pharmaceutical enterprises and pharmaceutical representatives In February 2017, the state health and Family Planning Commission and the State Administration of traditional Chinese medicine jointly issued the opinions on strengthening the construction of the marketing style of health and family planning system, proposing to formulate the implementation measures for information sharing and joint punishment of the health and family planning system credit reporting system After being recognized by the administrative organ, judged by the judicial organ or ruled by the arbitration institution, the institutions and The individual is listed in the credit system of the health and family planning system, publicized to the public, and the system of industry prohibition is implemented According to this document, the national large-scale hospital inspection continued to expand the coverage and depth In 2018, all level-3 medical institutions will carry out hospital inspection, and in 2020, all level-2 and above medical institutions will carry out hospital inspection We can see that although 2015-2017 has passed, anti-corruption is still going on 2018-2020 is a new year of anti-corruption pressure ▍ medical people, follow the policy! The two sessions have closed, bringing significant changes to the pharmaceutical market The State Food and drug administration has cancelled, the medical reform office has disappeared, the health and Family Planning Commission has changed its name, the state health insurance bureau has been established, the Supervision Commission has come, and the market environment will change as soon as the east wind blows For pharmaceutical enterprises, following the policy and adapting to the changes of various institutions should be focused on at present The State Supervision Commission has been set up to supervise the management personnel of public medical institutions According to xinhuanet.com, at present, from the central government to the provinces, cities and counties, the functions and institutions of anti-corruption, anti desecration and prevention departments of the four level procuratorates and 44151 procuratorial policemen have all completed their transfer on time As early as December 27, 2013, the national health and Family Planning Commission issued the provisions on the establishment of bad records of commercial bribery in the field of pharmaceutical purchase and sale, which clearly stipulated that: If the person in charge of the medical institution, the drug purchaser, the doctor and other relevant personnel accept the property or other benefits from the pharmaceutical production and operation enterprise and its agent, they shall be punished according to the provisions and their illegal income shall be confiscated; if the case is serious, the practicing doctor's practicing certificate shall be revoked by the health and family planning administration department; if the case constitutes a crime, they shall be investigated for criminal responsibility according to the law For the pharmaceutical production and operation enterprises and their agents once listed in the bad records of local commercial bribery, the public medical institutions or medical and health institutions receiving financial funds in the provincial region shall not purchase their drugs, medical equipment and medical consumables within two years after the list of bad records is published, and the public medical institutions or medical and health institutions receiving financial funds in other provincial regions shall not purchase their drugs, medical equipment and medical consumables within two years Score reduction shall be made to the products of the enterprise during internal bidding and purchase scoring For those listed in the bad records of commercial bribery twice or more within five years, all public medical institutions or medical and health institutions receiving financial funds shall not purchase their drugs, medical equipment and medical consumables within two years The administrative department of health and family planning shall establish a communication mechanism with the judicial organ and the relevant departments of supervision, finance, commerce, industry and commerce, food and drug supervision, etc., to inform each other of the information of commercial bribery cases in the field of medicine purchase and sale and the results of investigation and punishment On December 22, 2017, the measures for the administration of registration and filing of pharmaceutical representatives (Trial) (Draft for comments) jointly issued by the State Food and Drug Administration and the state health and Family Planning Commission clearly stated that pharmaceutical representatives shall not undertake the task of drug sales, shall not participate in the statistics of the number of drug prescriptions issued by individual doctors, shall not directly sell physical drugs, shall not collect and process purchase and sale bills, and shall not enter For commercial bribery, it is not allowed to directly provide donation and sponsorship to the internal departments and individuals of medical and health institutions; it is not allowed to mislead doctors to use drugs, exaggerate or mislead the efficacy, or conceal adverse drug reactions It can be seen that the State Supervision Commission has also become a department that pharmaceutical enterprises must pay attention to The anti-corruption policy will make the market investment of pharmaceutical enterprises more and more transparent, and the composition of market costs can be traced back to the actual behavior, so it is more and more difficult to fake If drug companies want to continue to use the sales model with gold, the cost of counterfeiting will be higher and higher Gold sales refers to the amount of prescriptions issued by doctors to give the corresponding Commission return Under the combination of the medical insurance bureau and the supervision committee, for pharmaceutical enterprises, the gold sales mode will be adjusted thoroughly to meet the changes of the situation and the needs of the policy In addition, after the implementation of the filing system, the adjustment of marketing mode will be a very big challenge for many pharmaceutical enterprises under the strangling effect of policies such as two vote system, zero plus, pharmaceutical custody, and secondary bargaining.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.